首页> 外文OA文献 >Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

【2h】

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

机译：尼古丁通过非小细胞肺癌异种移植模型中的α1 nAChR和EGFR之间的串扰诱导对厄洛替尼的耐药性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Li Heyan; Wang Shuo; Takayama Koichi; Harada Taishi; Okamoto Isamu; Iwama Eiji; Fujii Akiko; Ota Keiichi; Hidaka Noriko; Kawano Yuko; Nakanishi Yoichi;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Nicotine induces resistance to erlotinib via cross-talk between alpha 1 nAChR and EGFR in the non-small cell lung cancer xenograft model [J] . Li Heyan, Wang Shuo, Takayama Koichi, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2015,第1期

机译：在非小细胞肺癌异种移植模型中，尼古丁通过α1nAChR和EGFR之间的串扰诱导对厄洛替尼的耐药性
2. Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplification [J] . Koh Furugaki, Junko Fukumura, Toshiki Iwai, International Journal of Cancer =: Journal International du Cancer . 2016,第4期

机译：贝伐单抗联合厄洛替尼对T790M突变或MET扩增的EGFR突变非小细胞肺癌异种移植模型的影响
3. 9022 The nicotinic acetylcholine receptor (nAChR) subunit @a3 (CHRNA3) polymorphism in advanced non-small-cell lung cancer (NSCLC) patients (p) with EGFR mutations treated with erlotinib [J] . A.Cardona, J.L.Ramirez, I.De Aguirre, European Journal of Cancer Supplements . 2009,第2期

机译：9022厄洛替尼治疗的EGFR突变的晚期非小细胞肺癌（NSCLC）患者的烟碱乙酰胆碱受体（nAChR）亚基@ a3（CHRNA3）多态性
4. Profiling EGFR Kinase Inhibitor Resistance Pathways in Non-Small Lung Cancer Cells [C] . Ryan D. Bomgarden, Ryan Jacobs, Jason Fong, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：在非小肺癌细胞中的谱分析EGFR激酶抑制剂抵抗途径
5. Application of Quantitative Metrics for EGFR-Targeted Non-Small Cell Lung Cancer Therapy Using [11C]Erlotinib PET. [D] . Petrulli, Joseph Ryan. 2017

机译：定量指标在EGFR靶向非小细胞肺癌治疗中的应用[11C]厄洛替尼PET。
6. Reduced erlotinib sensitivity of EGFR mutant non-small cell lung cancer following cisplatin exposure: A cell culture model of second-line erlotinib treatment [O] . Tan Min Chin, Margaret P. Quinlan, Anurag Singh, -1

机译：顺铂暴露后降低的EGFR突变非小细胞肺癌的厄洛替尼敏感性：二线厄洛替尼治疗的细胞培养模型
7. Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation [O] . Eric Santoni-Rugiu, Morten Grauslund, Linea C. Melchior, 2017

机译：用Erlotinib治疗的EGFR外显子19-突变的非小细胞肺癌患者的异质性抗性机制：持久的FGFR3 - 抵抗，局部转化为EGFR - 估计SCLC，并获得T790M EGFR - 抵抗

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

著录项

引文网络

相似文献

相关主题

期刊订阅